Myelodysplastic syndromes, The Lancet, vol.383, issue.9936, pp.2239-2252, 2014. ,
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-2405, 2016. ,
Bone Marrow Failure as a Risk Factor for Clonal Evolution: Prospects for Leukemia Prevention, Hematology, vol.2007, issue.1, pp.40-46, 2007. ,
CHROMOSOME STUDIES IN HUMAN LEUKÆMIA, The Lancet, vol.274, issue.7100, pp.425-428, 1959. ,
Cytogenetic Studies in Acute Leukaemia, BMJ, vol.1, issue.5239, pp.1564-1571, 1961. ,
Cytogenetic analysis of 52 colorectal carcinomas--non-random aberration pattern and correlation with pathologic parameters, International Journal of Cancer, vol.55, issue.3, pp.422-428, 1993. ,
Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance, British Journal of Haematology, vol.182, issue.3, pp.437-440, 2017. ,
Constitutional trisomy 8 and Behçet syndrome, American Journal of Medical Genetics Part A, vol.149A, issue.5, pp.982-986, 2009. ,
Clinical Effect of Point Mutations in Myelodysplastic Syndromes, New England Journal of Medicine, vol.364, issue.26, pp.2496-2506, 2011. ,
Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation, Journal of Clinical Oncology, vol.32, issue.25, pp.2691-2698, 2014. ,
Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group, British Journal of Haematology, vol.33, issue.4, pp.451-458, 1976. ,
Proposals for the classification of the myelodysplastic syndromes, British Journal of Haematology, vol.51, issue.2, pp.189-199, 1982. ,
Classic and Molecular Cytogenetic Analyses Reveal Chromosomal Gains and Losses Correlated with Survival in Head and Neck Cancer Patients, Clin. Cancer Res, vol.11, pp.621-631, 2005. ,
Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution, Annals of Hematology, vol.89, issue.6, pp.545-551, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00516157
Commentary on and reprint of Block M, Jacobson LO, Bethard WF, Preleukemic acute human leukemia, in Journal of the American Medical Association (1953) 152:1018?1028, Hematology, vol.152, pp.285-297, 2000. ,
Role of chromosomal aberrations in clonal diversity and progression of acute myeloid leukemia, Leukemia, vol.29, issue.6, pp.1243-1252, 2015. ,
The 5q-syndrome, Blood, vol.84, issue.10, pp.3253-3260, 1994. ,
101 Apoptosis and fas antigen (CD95) expression in myclodysplasia, Leukemia Research, vol.21, issue.1, p.S26, 1997. ,
Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes, Leukemia, vol.11, issue.6, pp.839-845, 1997. ,
Identification of risk factors in atypical chronic myeloid leukemia, Haematologica, vol.91, pp.1566-1568, 2006. ,
8-trisomy in the bone marrow. Report of two cases, Clinical Genetics, vol.3, issue.6, pp.470-476, 2008. ,
MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia, Cancer Cell, vol.25, issue.5, pp.652-665, 2014. ,
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities, Blood, vol.104, issue.13, pp.4210-4218, 2004. ,
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities, Blood, vol.104, issue.13, pp.4210-4218, 2004. ,
Induction of myelodysplasia by myeloid-derived suppressor cells, Journal of Clinical Investigation, vol.123, issue.11, pp.4595-4611, 2013. ,
Incidence and Burden of the Myelodysplastic Syndromes, Current Hematologic Malignancy Reports, vol.10, issue.3, pp.272-281, 2015. ,
Cytogenetic, Clinical, and Morphologic Correlations in 78 Cases of Fibromatosis: A Report from the CHAMP Study Group, Mod. Pathol, vol.13, pp.1080-1085, 2000. ,
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes, Leukemia, vol.29, issue.1, pp.66-75, 2014. ,
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders, Nature Genetics, vol.42, issue.8, pp.722-726, 2010. ,
P53 gene mutations in acute myeloid leukemia with 17p monosomy, Blood, vol.78, issue.7, pp.1652-1657, 1991. ,
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q, Blood, vol.118, issue.14, pp.3765-3776, 2011. ,
"Preleukemia", Archives of Internal Medicine, vol.132, issue.2, p.226, 1973. ,
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes, Leukemia, vol.29, issue.7, pp.1458-1469, 2015. ,
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates, European Journal of Haematology, vol.80, issue.3, pp.197-200, 2008. ,
Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia, British Journal of Haematology, vol.145, issue.6, pp.788-800, 2009. ,
Defective Platelet Aggregation in Myelodysplastic Syndromes, Acta Haematologica, vol.118, issue.2, pp.117-122, 2007. ,
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes, Blood, vol.89, issue.6, pp.2079-2088, 1997. ,
Revised International Prognostic Scoring System for Myelodysplastic Syndromes, Blood, vol.120, issue.12, pp.2454-2465, 2012. ,
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology, Journal of the National Comprehensive Cancer Network, vol.15, issue.1, pp.60-87, 2016. ,
Fas ligand expression in the bone marrow in myelodysplastic syndromes correlates with FAB subtype and anemia, and predicts survival, Leukemia, vol.13, issue.1, pp.44-53, 1999. ,
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients, Blood, vol.110, issue.13, pp.4385-4395, 2007. ,
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes, Leukemia, vol.28, issue.2, pp.241-247, 2013. ,
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia, Journal of Clinical Oncology, vol.31, issue.19, pp.2428-2436, 2013. ,
CMML: Clinical and molecular aspects, International Journal of Hematology, vol.105, issue.6, pp.711-719, 2017. ,
Trisomy 8 in Acute Myeloblastic Leukemia and Sideroachrestic Anemia, Blood, vol.43, issue.4, pp.557-563, 1974. ,
ASXL1mutations in AML are associated with specific clinical and cytogenetic characteristics, Leukemia & Lymphoma, vol.59, issue.10, pp.2439-2446, 2018. ,
Chromosomal aberrations in workers exposed to low levels of benzene, Pharmacogenetics, vol.14, issue.7, pp.453-463, 2004. ,
Leukaemogenesis induced by an activating ?-catenin mutation in osteoblasts, Nature, vol.506, issue.7487, pp.240-244, 2014. ,
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 75% of Chronic Myelomonocytic Leukemia (CMML) by Detecting Frequent Alterations in TET2, RUNX1, CBL, and RAS., Blood, vol.114, issue.22, pp.417-417, 2009. ,
Autoimmune diseases and myelodysplastic syndromes, American Journal of Hematology, vol.91, issue.5, pp.E280-E283, 2016. ,
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease, Blood, vol.106, issue.6, pp.2183-2185, 2005. ,
Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q? syndrome, Blood, vol.118, pp.4666-4673, 2011. ,
, , 1995.
, Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations, Leukemia, vol.9, pp.370-381
Certain Autoimmune Manifestations Are Associated With Distinctive Karyotypes and Outcomes in Patients With Myelodysplastic Syndrome, Medicine, vol.95, issue.13, p.e3091, 2016. ,
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations, Blood, vol.125, pp.1367-1376, 2015. ,
Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro, Blood, vol.85, pp.3183-3190, 1995. ,
Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes, Journal of Clinical Oncology, vol.25, issue.23, pp.3503-3510, 2007. ,
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts, Blood, vol.126, issue.2, pp.233-241, 2015. ,
Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations, Br. J. Haematol, vol.162, pp.74-86, 2013. ,
Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders., Journal of Clinical Pathology, vol.36, issue.10, pp.1120-1128, 1983. ,
Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20% of cases, Genes, Chromosomes and Cancer, vol.33, issue.1, pp.93-97, 2001. ,
,
, Myelodysplastic Cells in Patients Reprogram Mesenchymal Stromal Cells to Establish a Transplantable Stem Cell Niche Disease Unit, Cell Stem Cell, vol.14, pp.824-837
Production of human pluripotent progenitor cell colony stimulating activity (CFU-GEMMCSA) in patients with myelodysplastic syndromes, Leukemia Research, vol.11, issue.3, pp.273-279, 1987. ,
Cytogenetic abnormalities in patients with severe aplastic anemia, Haematologica, vol.81, pp.418-422, 1996. ,
Ductal breast carcinoma develops through different patterns of chromosomal evolution, Genes. Chromosomes Cancer, vol.43, pp.147-154, 2005. ,
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure, Blood, vol.128, issue.9, pp.1246-1259, 2016. ,
Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms, Journal of Experimental Medicine, vol.212, issue.11, pp.1833-1850, 2015. ,
Myeloproliferative neoplasms: from origins to outcomes, Blood, vol.130, pp.2475-2483, 2017. ,
Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors, Blood, vol.108, pp.4170-4177, 2006. ,
Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis, Cancer, vol.123, issue.23, pp.4608-4616, 2017. ,
Chromosome abnormalities found among 34910 newborn children: results from a 13-year incidence study in ?rhus, Denmark, Human Genetics, vol.87, issue.1, pp.81-83, 1991. ,
Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level, Blood, vol.96, pp.2012-2021, 2000. ,
Involvement and functional impairment of the CD34+CD38?Thy-1+ hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8, Blood, vol.100, issue.1, pp.259-267, 2002. ,
Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, vol.122, pp.3616-3627, 2013. ,
Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review, British Journal of Haematology, vol.165, issue.3, pp.273-286, 2014. ,
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients, Leukemia, vol.28, issue.11, pp.2206-2212, 2014. ,
Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes, Pathologie Biologie, vol.55, issue.1, pp.37-48, 2007. ,
The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology, Cancer Genetics and Cytogenetics, vol.130, issue.2, pp.160-165, 2001. ,
Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia, British Journal of Haematology, vol.151, issue.5, pp.460-468, 2010. ,
Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia, Cancer Genetics and Cytogenetics, vol.75, issue.1, pp.6-10, 1994. ,
Treatment of MDS, Blood, vol.133, issue.10, pp.1096-1107, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-00549427
Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia, Nature, vol.464, issue.7290, pp.852-857, 2010. ,
Smoldering Acute Leukemia, New England Journal of Medicine, vol.268, issue.15, pp.812-815, 1963. ,
Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome, Cancer Cell, vol.24, issue.1, pp.90-104, 2013. ,
Haematopoietic development and leukaemia in Down syndrome, British Journal of Haematology, vol.167, issue.5, pp.587-599, 2014. ,
Chromosome Studies in Preleukemia, Blood, vol.27, issue.6, pp.782-799, 1966. ,
Preleukemia, The American Journal of Medicine, vol.55, issue.1, pp.38-48, 1973. ,
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes, British Journal of Haematology, vol.159, issue.3, pp.311-321, 2012. ,
P-068 Trisomy 8 in de novo MDS, constitutional or not constitutional?, Leukemia Research, vol.37, p.S53, 2013. ,
Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?, PLOS ONE, vol.10, issue.6, p.e0129375, 2015. ,
Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes, Leukemia Research, vol.27, issue.7, pp.583-591, 2003. ,
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge, Journal of Clinical Oncology, vol.30, issue.8, pp.820-829, 2012. ,
Detailed analysis of clonal evolution and cytogenetic evolution patterns in patients with myelodysplastic syndromes (MDS) and related myeloid disorders, Blood Cancer Journal, vol.8, issue.3, 2018. ,
Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups, Genes, Chromosomes and Cancer, vol.45, issue.12, pp.1164-1168, 2006. ,
Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine, Leukemia Research, vol.63, pp.72-77, 2017. ,
Constitutional trisomy 8 as first mutation in multistep carcinogenesis: Clinical, cytogenetic, and molecular data on three cases, Genes, Chromosomes and Cancer, vol.17, issue.2, pp.94-101, 1996. ,
Epidemiology, Natural History, and Practice Patterns of Patients with Myelodysplastic Syndromes in 2010, Journal of the National Comprehensive Cancer Network, vol.9, issue.1, pp.57-63, 2011. ,
Stem and progenitor cell alterations in myelodysplastic syndromes, Blood, vol.129, issue.12, pp.1586-1594, 2017. ,
High Incidence of Gastrointestinal Ulceration and Cytogenetic Aberration of Trisomy 8 as Typical Features of Behçet?s Disease Associated with Myelodysplastic Syndrome: A Series of 16 Consecutive Chinese Patients from the Shanghai Behçet?s Disease Database and Comparison with the Literature, BioMed Research International, vol.2018, pp.1-8, 2018. ,
Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities, Blood, vol.100, issue.13, pp.4427-4432, 2002. ,
Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities, Blood, vol.100, issue.13, pp.4427-4432, 2002. ,
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome, Blood, vol.106, issue.3, pp.841-851, 2005. ,
Factors Affecting Response and Survival in Patients With Myelodysplasia Treated With Immunosuppressive Therapy, Journal of Clinical Oncology, vol.26, issue.15, pp.2505-2511, 2008. ,
T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy, Blood, vol.117, issue.9, pp.2691-2699, 2011. ,
Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells, Carcinogenesis, vol.21, issue.8, pp.1485-1490, 2000. ,
Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells, Carcinogenesis, vol.21, issue.8, pp.1485-1490, 2000. ,
How I treat chronic myelomonocytic leukemia, Blood, vol.130, issue.2, pp.126-136, 2017. ,
Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes, Haematologica, vol.90, pp.1168-1178, 2005. ,
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia, Nature Reviews Cancer, vol.17, issue.1, pp.5-19, 2016. ,
Myeloproliferative Neoplasms, New England Journal of Medicine, vol.376, issue.22, pp.2168-2181, 2017. ,
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes, Blood, vol.126, issue.1, pp.9-16, 2015. ,
Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice, Blood, vol.123, issue.7, pp.1069-1078, 2014. ,
Risk factors of myelodysplastic syndromes: a case?control study, Leukemia, vol.19, issue.11, pp.1912-1918, 2005. ,
Cytogenetic risk stratification in chronic myelomonocytic leukemia, Haematologica, vol.96, issue.3, pp.375-383, 2010. ,
Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution, American Journal of Hematology, vol.89, issue.8, pp.813-818, 2014. ,
Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution, American Journal of Hematology, vol.89, issue.8, pp.813-818, 2014. ,
Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms, Blood, vol.75, issue.9, pp.1770-1773, 1990. ,
Genetic alterations of the cohesin complex genes in myeloid malignancies, Blood, vol.124, issue.11, pp.1790-1798, 2014. ,
Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms, Leukemia, vol.28, issue.1, pp.78-87, 2013. ,
The World Health Organization (WHO) classification of the myeloid neoplasms, Blood, vol.100, issue.7, pp.2292-2302, 2002. ,
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes, Blood, vol.114, issue.5, pp.937-951, 2009. ,
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics, Proceedings of the National Academy of Sciences, vol.98, issue.3, pp.1124-1129, 2001. ,
TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes, Leukemia Research, vol.37, issue.3, pp.305-311, 2013. ,
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients, British Journal of Haematology, vol.169, issue.1, pp.71-76, 2014. ,
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study, American Journal of Hematology, vol.89, issue.12, pp.1111-1115, 2014. ,
Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome, Pediatrics International, vol.61, issue.3, pp.222-229, 2019. ,
Toll-like receptor alterations in myelodysplastic syndrome, Leukemia, vol.27, issue.9, pp.1832-1840, 2013. ,
Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies, Cancer Genetics and Cytogenetics, vol.149, issue.2, pp.137-153, 2004. ,
OP0053 Inflammatory disorders associated with trisomy 8 myelodysplastic syndromes : french retrospective case control study, WEDNESDAY, 13 JUNE 2018, vol.0, pp.1-7, 2018. ,
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations, Blood, vol.120, issue.10, pp.2076-2086, 2012. ,
Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo, Cancer Cell, vol.25, issue.6, pp.794-808, 2014. ,
Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study, Blood, vol.100, issue.1, pp.29-35, 2002. ,
Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes, Tumor Biology, vol.37, issue.4, pp.4633-4640, 2015. ,
Myelodysplastic syndromes. The Lancet, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, vol.383, pp.2239-2252, 2014. ,
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, issue.20, pp.2391-2405, 2016. ,
Cytogenetic findings in WHO-defined polycythaemia vera and their prognostic relevance, British Journal of Haematology, vol.182, issue.3, pp.437-440, 2017. ,
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders, Nature Genetics, vol.42, issue.8, pp.722-726, 2010. ,
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders, Nature Genetics, vol.42, pp.722-726, 2010. ,
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q, Blood, vol.118, issue.14, pp.3765-3776, 2011. ,
Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates, European Journal of Haematology, vol.80, issue.3, pp.197-200, 2008. ,
Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia, British Journal of Haematology, vol.145, issue.6, pp.788-800, 2009. ,
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes, Blood, vol.89, issue.6, pp.2079-2088, 1997. ,
Revised International Prognostic Scoring System for Myelodysplastic Syndromes, Blood, vol.120, issue.12, pp.2454-2465, 2012. ,
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes, Leukemia, vol.28, issue.2, pp.241-247, 2013. ,
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia, Journal of Clinical Oncology, vol.31, issue.19, pp.2428-2436, 2013. ,
Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 75% of Chronic Myelomonocytic Leukemia (CMML) by Detecting Frequent Alterations in TET2, RUNX1, CBL, and RAS., Blood, vol.114, issue.22, pp.417-417, 2009. ,
PTPN11 Mutational Spectrum in Juvenile Myelomonocytic Leukemia and Noonan Syndrome., Blood, vol.104, issue.11, pp.3417-3417, 2004. ,
Cytogenetic abnormalities in patients with severe aplastic anemia, Haematologica, vol.81, pp.418-422, 1996. ,
Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer, 2017. ,
Cohesin loss alters adult hematopoietic stem cell homeostasis, leading to myeloproliferative neoplasms, Journal of Experimental Medicine, vol.212, pp.1833-1850, 2015. ,
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients, Leukemia, vol.28, issue.11, pp.2206-2212, 2014. ,
Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes, Pathologie Biologie, vol.55, issue.1, pp.37-48, 2007. ,
The incidence of trisomy 8 as a sole chromosomal aberration in myeloid malignancies varies in relation to gender, age, prior iatrogenic genotoxic exposure, and morphology, Cancer Genetics and Cytogenetics, vol.130, pp.460-468, 2001. ,
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes, British Journal of Haematology, vol.159, issue.3, pp.311-321, 2012. ,
Impact of trisomy 8 on expression of genes located on chromosome 8 in different AML subgroups, Genes, Chromosomes and Cancer, vol.45, issue.12, pp.1164-1168, 2006. ,
Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine, Leukemia Research, vol.63, pp.72-77, 2017. ,
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome, Blood, vol.106, issue.3, pp.841-851, 2005. ,
) Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogen etica Hematol ogica, British Journal of Haematology, vol.108, pp.346-356, 2000. ,
Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution, American Journal of Hematology, vol.89, issue.8, pp.813-818, 2014. ,
Genetic alterations of the cohesin complex genes in myeloid malignancies, Blood, vol.124, issue.11, pp.1790-1798, 2014. ,
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics, Proceedings of the National Academy of Sciences, vol.98, issue.3, pp.1124-1129, 2001. ,
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics, Proceedings of the National Academy of Sciences, vol.98, issue.3, pp.1124-1129, 2001. ,
TET2, ASXL1 and EZH2 mutations in Chinese with myelodysplastic syndromes, Leukemia Research, vol.37, issue.3, pp.305-311, 2013. ,
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study, American Journal of Hematology, vol.89, issue.12, pp.1111-1115, 2014. ,
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients, British Journal of Haematology, vol.169, issue.1, pp.71-76, 2014. ,
Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study, Blood, vol.100, issue.1, pp.29-35, 2002. ,
Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes, Tumor Biology, vol.37, issue.4, pp.4633-4640, 2015. ,